In: BMC Cancer, 17 (2017), Nr. 128. S. 1-7. ISSN 1471-2407
Vorschau |
PDF, Englisch
Download (505kB) | Lizenz: ![]() |
Abstract
Background: Skeletal involvement (SI) is observed at low prevalence in patients with diffuse large B-cell lymphoma (DLBCL). Due to the rareness of this particular condition, prospective trials for these patients are scarce. Methods: We analyzed clinical characteristics and outcome of 75 patients with DLBCL and SI in order to identify factors with prognostic impact towards progression-free survival (PFS) and overall survival (OS). Results: Limited stage disease (Ann Arbor stage IE-IIE) was present in 34 patients (45%), 41 patients (55%) had advanced stage disease (Ann Arbor stage IIIE-IVE). Outcome was generally favorable for patients with DLBCL and SI with 3-year OS of 83%. The international prognostic index (IPI) was able to distinguish between different risk groups within this specific entity. Additionally, hypercalcemia showed to be a factor significantly associated with inferior survival. In regard to first-line treatment modalities, consolidative radiotherapy was positively associated with prolonged PFS and OS while intensification of chemotherapy had no significant impact. Conclusions: In our cohort of patients with DLBCL and SI, high-risk IPI as well as presence of hypercalcemia were associated with inferior outcome. Consolidative radiotherapy had a positive impact on survival.
Dokumententyp: | Artikel |
---|---|
Titel der Zeitschrift: | BMC Cancer |
Band: | 17 |
Nummer: | 128 |
Verlag: | BioMed Central; Springer |
Ort der Veröffentlichung: | London; Berlin; Heidelberg |
Erstellungsdatum: | 14 Feb. 2017 13:35 |
Erscheinungsjahr: | 2017 |
ISSN: | 1471-2407 |
Seitenbereich: | S. 1-7 |
Institute/Einrichtungen: | Zentrale und Sonstige Einrichtungen > Deutsches Krebsforschungszentrum
Medizinische Fakultät Heidelberg und Uniklinikum > Medizinische Universitäts-Klinik und Poliklinik |
DDC-Sachgruppe: | 610 Medizin |